Safety and Immunogenicity of Skyvaricella Injection in Healthy Volunteer Vietnamese Children From 12 Months to 12 Years Old

PHASE4CompletedINTERVENTIONAL
Enrollment

201

Participants

Timeline

Start Date

April 17, 2021

Primary Completion Date

July 6, 2021

Study Completion Date

April 19, 2022

Conditions
Chickenpox
Interventions
BIOLOGICAL

Skyvaricella Injection

"The main target is evaluating the safety of SKYVaricella injection in healthy Vietnamese children from 12 months to 12 years, with a single injection.~The secondary target is to Assess the immunogenicity of SKYVaricella inj. in a small group of healthy Vietnamese children from 12 months to 12 years, with a single injection."

Trial Locations (1)

18000

CDC Ha Nam, Phủ Lý

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Vabiotech

INDUSTRY

lead

Vietnam Military Medical University

OTHER

NCT04384016 - Safety and Immunogenicity of Skyvaricella Injection in Healthy Volunteer Vietnamese Children From 12 Months to 12 Years Old | Biotech Hunter | Biotech Hunter